| Katy Tarella, LICSW | |
|
115 Mill St, Mailstop 137, Belmont, MA 02478-1064 | |
| (617) 855-4178 | |
| Not Available |
| Full Name | Katy Tarella |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 115 Mill St, Belmont, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003358433 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 119934 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katy Tarella, LICSW 115 Mill St, Mailstop 137, Belmont, MA 02478-1064 Ph: () - | Katy Tarella, LICSW 115 Mill St, Mailstop 137, Belmont, MA 02478-1064 Ph: (617) 855-4178 |
News Archive
Waterlogic water dispensers with Firewall UV technology, have become the world's first bottle-less water coolers to be awarded dual certification for achieving the highest levels of drinking water purification.
An international team of researchers comparing recently-developed methods for diagnosing tuberculosis in children in resource-poor countries has concluded that the best test for high-risk children is the microscopic-observation drug-susceptibility (MODS) technique using two gastric aspirate specimens from each child tested. MODS detects the presence of bacteria causing tuberculosis using microscopes to detect typical growth patterns in culture broth.
The Obama administration signals that it will challenge a federal judge's order that would make an emergency contraception drug available over-the-counter to women of all ages. The move comes a day after the FDA said the contraception should be available in that way to anyone older than 15.
Researchers have identified the dose of dengue virus in human blood that is required to infect mosquitoes when they bite. Mosquitoes are essential for transmitting the virus between people so the findings have important implications for understanding how to slow the spread of the disease.
Orexigen® Therapeutics, Inc. today announced results from new intent to treat (ITT) analyses from the COR-I and COR-II Phase 3 trials of Contrave® (naltrexone SR/bupropion SR), the first of two late stage Orexigen candidates for the treatment of obesity. These data expand on top-line results announced in July and complement findings from a panel discussion on Saturday where the Company presented data on Contrave patients who completed 56 weeks of therapy.
› Verified 1 days ago
Miqveh Steinhart, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3118 | |
Joan Martha Cottler, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3623 | |
Perrie T Merlin, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-2321 | |
Brigitte Giber, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 51 Bow Rd, Belmont, MA 02478 Phone: 617-932-9564 | |
Ms. Megan Ray, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-4033 Fax: 617-855-3709 | |
Kaitlin Barnea, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3296 |